ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.670
+0.080 (5.03%)
Apr 24, 2026, 4:00 PM EDT - Market closed
ALX Oncology Holdings Employees
ALX Oncology Holdings had 43 employees as of December 31, 2025. The number of employees decreased by 37 or -46.25% compared to the previous year.
Employees
43
Change
-37
Growth
-46.25%
Revenue / Employee
n/a
Profits / Employee
-$2,365,000
Market Cap
224.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 43 | -37 | -46.25% |
| Sep 30, 2025 | 44 | -45 | -50.56% |
| Jun 30, 2025 | 49 | -32 | -39.51% |
| Mar 31, 2025 | 65 | -9 | -12.16% |
| Dec 31, 2024 | 80 | 8 | 11.11% |
| Sep 30, 2024 | 89 | 18 | 25.35% |
| Jun 30, 2024 | 81 | 9 | 12.50% |
| Mar 31, 2024 | 74 | 9 | 13.85% |
| Dec 31, 2023 | 72 | 14 | 24.14% |
| Sep 30, 2023 | 71 | 16 | 29.09% |
| Jun 30, 2023 | 72 | 20 | 38.46% |
| Mar 31, 2023 | 65 | 21 | 47.73% |
| Dec 31, 2022 | 58 | 15 | 34.88% |
| Sep 30, 2022 | 55 | 23 | 71.88% |
| Jun 30, 2022 | 52 | 23 | 79.31% |
| Mar 31, 2022 | 44 | 20 | 83.33% |
| Dec 31, 2021 | 43 | 20 | 86.96% |
| Sep 30, 2021 | 32 | 15 | 88.24% |
| Jun 30, 2021 | 29 | 10 | 52.63% |
| Mar 31, 2021 | 24 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Heron Therapeutics | 128 |
| MediWound | 121 |
| Keros Therapeutics | 78 |
| Camp4 Therapeutics | 48 |
| Milestone Pharmaceuticals | 38 |
| Fennec Pharmaceuticals | 35 |
| Elicio Therapeutics | 33 |
ALXO News
- 9 days ago - ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules - GlobeNewsWire
- 13 days ago - ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer - GlobeNewsWire
- 7 weeks ago - ALX Oncology Holdings Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - ALX Oncology Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 - GlobeNewsWire
- 2 months ago - ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 - GlobeNewsWire
- 3 months ago - ALX Oncology Announces Pricing of Underwritten Offering - GlobeNewsWire